Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06431815 · ClinicalTrials.gov registry record
ADVENT Post Approval Study
A clinical trial of Paroxysmal Atrial Fibrillation, sponsored by Boston Scientific Corporation.
- Active
- Registry status
- 228
- Enrollment target
- 20
- Study locations
NCT06431815 is a study of Paroxysmal Atrial Fibrillation that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 228 participants, below the 850-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (73% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT06431815, a study of Paroxysmal Atrial Fibrillation, is active but no longer recruiting, sponsored by Boston Scientific Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- 228 participants
- Enrollment target
- 20
- Study locations
Study Summary
The ADVENT Post Approval Study (PAS) is a prospective, global, multicenter, observational study.
Conditions Studied
Interventions
- DEVICE FARAPULSE™ Pulsed Field Ablation System
Study Locations (20)
Florida
- Florida Heart Rhythm Specialists, PLLC - Fort Lauderdale
- Baptist Medical Center - Jacksonville
- Mount Sinai Medical Center - Miami Beach
- Tallahassee Memorial Hospital - Tallahassee
- AdventHealth Tampa - Tampa
New York
- New York Hospital Queens - Flushing
- Columbia University Medical Center - New York
- Northwell Health - New York
- Montefiore Medical Center - The Bronx
Alabama
- Mobile Infirmary Medical Center - Mobile
Arizona
- Scottsdale Healthcare - Shea - Scottsdale
California
- Alta Bates Summit Medical Center - Oakland
District of Columbia
- Washington Hospital Center - Washington D.C.
Georgia
- Memorial Health University Medical Center - Savannah
Louisiana
- Ochsner Clinic Foundation - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2024-09-25 |
| Est. Completion | 2029-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06431815
The ClinicalTrials.gov registry entry for NCT06431815 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 850-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (73% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which FARAPULSE™ Pulsed Field Ablation System is the first listed.
NCT06431815 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, New York, Alabama.
Frequently Asked Questions
What is clinical trial NCT06431815 about?
NCT06431815 is a clinical study titled "ADVENT Post Approval Study". The ADVENT Post Approval Study (PAS) is a prospective, global, multicenter, observational study.
What is the current status of trial NCT06431815?
This trial is currently active not recruiting. The enrollment target is 228 participants. The study started on 2024-09-25. Estimated completion is 2029-10.
What conditions does trial NCT06431815 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation.
What interventions are being tested in trial NCT06431815?
The interventions under investigation include: FARAPULSE™ Pulsed Field Ablation System (DEVICE).
Who is sponsoring clinical trial NCT06431815?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06431815 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
RECRUITING
-
STOP AF First Post-Approval Study
RECRUITING
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RECRUITING
-
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
RECRUITING
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.